HIV prevention strategies used by serodiscordant couples

Organisation: Position: Deadline Date: Location:

Two years ago, the Opposites Attract study found no transmissions between 343 regular gay couples of differing HIV status where the HIV-positive partner had a viral load under 200 copies/ml, the negative partner was not taking PrEP, and they did not use a condom. In doing so, alongside the PARTNER study, it provided the evidence that people with HIV who had an undetectable viral load were not infectious or, to quote the slogan that has become a global brand, undetectable = untransmittable (U=U).

A new analysis has now delved deeper into the actual sex and prevention behaviour of those who took part in Opposites Attract and found that couples were by no means just relying on the positive partner’s undetectable viral load to avoid the negative partner becoming infected. Some used different strategies altogether, while others combined strategies in a ‘belt-and-braces’ fashion.

This study looks at couple’s sexual prevention behaviours at all time points in the study. The previous analysis, of whether there was any risk of transmission by the HIV-positive partner if he had an undetectable viral load, excluded all sex acts that were covered by condoms or PrEP. In fact, a high proportion of couples continued to use condoms all or some of the time and a third of the negative partners took pre-exposure prophylaxis (PrEP) during at least part of the study.

There was also high usage of ‘seropositioning’ (the HIV-negative partner taking the insertive role and the positive partner the receptive role), which also reduces the risk of HIV, but because some risk still remains, times when couples practised seropositioning were not excluded.

Opposites Attract started in Australia but later extended to sites in Brazil and Thailand, and there were interesting differences between the HIV prevention choices in the different countries. In Thailand in particular, a high proportion of the HIV-positive partners had not started antiretroviral therapy (ART) when they entered the study, though nearly all had by its end. Viral load tests are conducted less often there, and this may explain why Thai participants were more likely to use condoms or PrEP, alone or in combination, as their main protective behaviour.

The analysis provides an interesting snapshot of how gay men’s sexual risk and HIV prevention behaviour was changing during a period of transition when universal ART on diagnosis was becoming established and PrEP was becoming more available, but the awareness of them both was perhaps spreading more slowly.

This new analysis includes all 343 couples from the original study: 153 in Australia, 93 in Brazil and 97 in Thailand. The study started in 2012 in Australia and in 2014 in Brazil and Thailand, before closing at the end of 2016. The Brazilian and Thai participants therefore contributed fewer couple-years of data to the analysis.

The average age of participants was 35 years and 10 months, with almost no difference between the HIV-positive and negative partners. The Australians tended to be older (around 40 years) than the Thais (around 30 years). The HIV-positive partners were somewhat less likely to be university-educated: 4% less likely in Thailand and Brazil, and 8% less likely in Australia.

Just over 40% of couples had been in their sexual relationship for less than a year, about a third from one to five years, and just under a quarter more than five years. Brazilian and Thai couples were more likely to have been together for less than a year (54% and 46% respectively) and less likely to have been together for over five years (15% and 17.5%).

As already mentioned, not all of the HIV-positive participants were on ART when they entered the study – 85% of Australians and 80% of Brazilians were, but only 50.5% of Thais. All but six participants were on ART by the end of the study. Not surprisingly then, whereas 85% of Australians and 81% of Brazilians had viral loads below 200 copies/ml throughout the study, only 55% of Thais did.

The differences in the availability of ART were reflected in participants’ prevention strategies. For instance, during the study, 11% of Australians, 31% of Brazilians, and 45% of Thais never had condomless anal sex, meaning that up to a quarter of all participants continued relying on condoms as their sole prevention method, or one of them, and 47% of all acts of anal intercourse in the study involved using a condom.

Multiple prevention methods were used: one of the surprises of the study was the high proportion of people who used what was defined as “daily PrEP” at least part of the time. A third of the HIV-negative participants recorded at least some PrEP use, and usage was higher in Brazil and Thailand (40% and 37%) than Australia (27%).

Some participants may have obtained PrEP via the Princess PrEP programme in Thailand and the demo projects in Australian states such as EPIC-NSW, which both started in early 2016, but PrEP was not available in Brazil officially until 2017. Even allowing for confusion between PrEP and PEP (post-exposure prophylaxis), there seems to have been significant online purchasing of PrEP or other informal sourcing among participants.

The researchers took all acts of anal intercourse recorded during the study and classed each as to whether it offered protection from HIV via one or more of four effective methods: the perceived viral undetectability of the HIV-positive partner (U=U): 77% of all acts were covered by this; seropositioning which offers a 90% reduction in the chance of HIV transmission when used consistently: 62% of all acts were covered by this; condom use by either partner: 47% of all acts were covered by condoms; and PrEP use by the negative partner: 24% of all acts were covered by PrEP.

As can be seen, these figures are not exclusive and most couples used more than one way to protect themselves. For U=U, the proportion of sex acts covered only by this and no other method was just 12%. With condoms, seropositioning and PrEP, only 5%, 3% and 1% of sex acts respectively were covered by this one method alone.

The most popular strategy (assuming it was a deliberate strategy) was to add in seropositioning. The ‘top five’ of mixed strategies were: U=U and seropositioning: 23% of all acts; condoms, U=U and seropositioning: 12% of all acts; condoms and U=U: 9% of all acts; condoms and seropositioning: 9% of all acts; and U=U, PrEP and seropositioning: 7% of all acts.

Where the HIV-positive partner was perceived as undetectable, condoms were also used (in any combination) 38% of the time, and PrEP was also used 10% of the time.
Just 4% of anal sex acts were covered by all four strategies but conversely only 1.6% were not covered by any strategy – i.e. the positive partner was detectable, neither condoms nor PrEP were used, and the negative partner was receptive.

There were strong differences between countries. Thais and Brazilians were very much more likely to use condoms than Australians: 85% of all anal sex involved using a condom in Thai participants and 64% in Brazilians, versus 26% of Australians. Thais were also more likely than others to use condoms and PrEP (21% of all sex acts involved both) and while the absolute number using PrEP was smaller than for other methods, two-thirds of Thais who did use PrEP used it as their sole method of protection.

Lumping together U=U and PrEP, 69% of Australians used one or both of these as their sole protection versus 35% of Brazilians and only 5% of Thais. Only 5% of participants used strategic positioning as their sole prevention method but it was used by 10% of Thais.

The data begs the question: were the partners correct about the HIV-positive partner’s viral load? The answer is: in Australia and Brazil, most of the time (88% and 78% respectively). In Thailand, possibly because viral load testing is less common, partners were more likely to perceive their partner’s viral load as detectable when in fact it was not (61%).
If the positive partner did have a viral load over 200 copies/ml, the negative partner was generally correct in either knowing this, or saying he did not know his viral load.

Reassuringly, there were very few cases – just 15 in all – where the negative partner thought their partner’s viral load was undetectable but it wasn’t: just 1% in Australia, 1.2% in Brazil and no cases at all in Thailand. Nonetheless, in all these 15 cases, the HIV-positive partner had a viral load of over 1000 copies/ml and therefore was potentially infectious.

Introduction: There are few data about the range of strategies used to prevent sexual HIV transmission within gay male serodiscordant couples. We examined HIV prevention strategies used by such couples and compared differences between countries.
Methods: Opposites Attract was a cohort study of male serodiscordant couples in Australia, Brazil and Thailand, from May 2014 (Australia) or May 2016 (Brazil/Thailand) to December 2016. At visits, HIV‐positive partners had viral load (VL) tested; HIV‐negative partners reported sexual behaviour and perceptions of their HIV‐positive partner’s VL results. Within‐couple acts of condomless anal intercourse (CLAI) were categorized by strategy: condom‐protected, biomedically protected (undetectable VL and/or pre‐exposure prophylaxis [PrEP]), or not protected by either (HIV‐negative partners engaging in insertive CLAI, receptive CLAI with withdrawal, or receptive CLAI with ejaculation).
Results: A total of 343 couples were included in this analysis (153 in Australia, 93 in Brazil and 97 in Thailand). Three‐quarters of HIV‐positive partners were consistently virally suppressed (<200 copies/mL) during follow‐up, and HIV‐negative partners had correct perceptions of their partner’s VL result for 76.5% of tests. One‐third of HIV‐negative partners used daily PrEP during follow‐up. Over follow‐up, 73.8% of couples had CLAI. HIV‐negative partners reported 31,532 acts of anal intercourse with their HIV‐positive partner. Of these, 46.7% were protected by condoms, 48.6% by a biomedical strategy and 4.7% of acts were not protected by these strategies. Australian couples had fewer condom‐protected acts and a higher proportion of biomedically protected acts than Brazilian and Thai couples. Of the 1473 CLAI acts where the perceived VL was detectable/unknown and were not protected by PrEP (4.7% of all acts), two‐thirds (n = 983) were when the HIV‐negative partner was insertive (strategic positioning). Of the 490 acts when the HIV‐negative partner was receptive, 261 involved withdrawal and 280 involved ejaculation. Thus, <1% of acts were in the highest risk category of receptive CLAI with ejaculation.
Conclusions: Couples used condoms, PrEP or perceived undetectable VL for prevention in the majority of anal intercourse acts. Only a very small proportion of events were not protected by these strategies. Variation between countries may reflect differences in access to HIV treatment, education, knowledge and attitudes.

Benjamin R Bavinton, Garrett P Prestage, Fengyi Jin, Nittaya Phanuphak, Beatriz Grinsztejn, Christopher K Fairley, David Baker, Jennifer Hoy, David J Templeton, Ban K Tee, Anthony Kelleher, Andrew E Grulich

Aidsmap material
Journal of the International Aids Society abstract

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.